BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 897683)

  • 21. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS
    Adv Biochem Psychopharmacol; 1978; 19():217-33. PubMed ID: 29447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous and drug-induced rotation following localized 6-hydroxydopamine and kainic acid-induced lesions of the neostriatum.
    Dunnett SB; Iversen SD
    Neuropharmacology; 1982 Sep; 21(9):899-908. PubMed ID: 6815549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 25. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of nigrostriatal dopamine neurons in the contraversive rotational behavior evoked by electrical stimulation of the lateral hypothalamus.
    Castañeda E; Robinson TE; Becker JB
    Brain Res; 1985 Feb; 327(1-2):143-51. PubMed ID: 3921190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
    Neve KA; Kozlowski MR; Marshall JF
    Brain Res; 1982 Jul; 244(1):33-44. PubMed ID: 6288182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the acoustic startle response by dopamine agonists after 6-hydroxydopamine lesions of the substantia nigra pars compacta: corresponding changes in c-Fos expression in the caudate-putamen.
    Meloni EG; Davis M
    Brain Res; 2000 Oct; 879(1-2):93-104. PubMed ID: 11011010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways.
    Turski L; Havemann U; Kuschinsky K
    Behav Brain Res; 1982 Aug; 5(4):415-22. PubMed ID: 6289848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dopamine-sensitive striatal efferent system mapped with [14C]deoxyglucose in the rat.
    Brown LL; Wolfson LI
    Brain Res; 1983 Feb; 261(2):213-29. PubMed ID: 6831209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs.
    Andén NE
    Pharmacol Ther B; 1975; 1(3):371-80. PubMed ID: 772707
    [No Abstract]   [Full Text] [Related]  

  • 32. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 34. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ; Pinder RM
    J Pharm Pharmacol; 1974 Oct; 26(10):753-6. PubMed ID: 4156532
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a non-dopaminergic nigrostriatal pathway?
    van der Kooy D; Coscina DV; Hattori T
    Neuroscience; 1981; 6(3):345-57. PubMed ID: 7012667
    [No Abstract]   [Full Text] [Related]  

  • 36. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical lesions interfere with behavioral recovery from unilateral substantia nigra lesions induced by brain grafts.
    Freed WJ; Cannon-Spoor HE
    Behav Brain Res; 1989 Apr; 32(3):279-88. PubMed ID: 2713080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of apomorphine-induced rotational behaviour in rats following the combination of 6-hydroxydopamine and electrolytic lesions in the substantia nigra.
    Watanabe H; Watanabe K
    Jpn J Pharmacol; 1979 Feb; 29(1):93-104. PubMed ID: 459160
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of globus pallidus and substantia nigra efferent pathways in striatally evoked head turning in the rat.
    Lee LA; Slater P
    Exp Brain Res; 1981; 44(2):170-6. PubMed ID: 7286105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.